Production, purification and characterization of adeno-associated vectors.
about
SCHEMA computational design of virus capsid chimeras: calibrating how genome packaging, protection, and transduction correlate with calculated structural disruption.Scalable downstream strategies for purification of recombinant adeno- associated virus vectors in light of the properties.AAV-mediated pancreatic overexpression of Igf1 counteracts progression to autoimmune diabetes in mice.Ubiquitin-independent proteasomal degradation during oncogenic viral infections.Single point mutation in adeno-associated viral vectors -DJ capsid leads to improvement for gene delivery in vivoAdeno-associated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules.Hepatic fatty acid trafficking: multiple forks in the roadNerve surgery and gene therapy: a neurobiological and clinical perspective.Nanotechnology to drive stem cell commitment.Manufacturing of recombinant adeno-associated viral vectors: new technologies are welcomeRational plasmid design and bioprocess optimization to enhance recombinant adeno-associated virus (AAV) productivity in mammalian cells.Gene therapy approaches in the non-human primate model of Parkinson's disease.Adeno-Associated Virus (AAV) as a Vector for Gene Therapy.Strategies and methods for the detection and identification of viral vectors.Identification of an adeno-associated virus binding epitope for AVB sepharose affinity resinSimple downstream process based on detergent treatment improves yield and in vivo transduction efficacy of adeno-associated virus vectors.NT-3 promotes proprioceptive axon regeneration when combined with activation of the mTor intrinsic growth pathway but not with reduction of myelin extrinsic inhibitors.Biochemical, histological and functional correction of mucopolysaccharidosis type IIIB by intra-cerebrospinal fluid gene therapy.Molecular design for recombinant adeno-associated virus (rAAV) vector production.Gene therapy with the TRF1 telomere gene rescues decreased TRF1 levels with aging and prolongs mouse health span.Novel approaches to render stable producer cell lines viable for the commercial manufacturing of rAAV-based gene therapy vectors.Universal Method for the Purification of Recombinant AAV Vectors of Differing Serotypes.Emerging Issues in AAV-Mediated In Vivo Gene Therapy.Postinjury Induction of Activated ErbB2 Selectively Hyperactivates Denervated Schwann Cells and Promotes Robust Dorsal Root Axon Regeneration.Large-Scale Transient Transfection of Suspension Mammalian Cells for VLP Production.Angiotensin 1-7 Overexpression Mediated by a Capsid-optimized AAV8 Vector Leads to Significant Growth Inhibition of Hepatocellular Carcinoma In vivo.Ultrafiltered recombinant AAV8 vector can be safely administered in vivo and efficiently transduces liver.A Recombinant Baculovirus Efficiently Generates Recombinant Adeno-Associated Virus Vectors in Cultured Insect Cells and Larvae.
P2860
Q31125144-6C32C258-A7D5-4EE8-9F3D-D2ADCD3E3902Q33555259-E9F2B6A2-C0EE-4F1B-9FE6-E4333C00559FQ33836234-D1EFAAD7-673A-4B8D-94E2-B52D06E9EAA0Q35354212-9A675A58-0A8B-4C0E-94F0-3396319F1136Q35884767-7F44BE10-021C-4F8A-8CDE-29C74458F8F4Q36827430-3E1BFBAB-BA9F-4401-8774-22F16301A20EQ37296476-7F0CE1C4-4245-4E2E-98AA-F01F875D1DCDQ37931558-5D99EA94-4368-458A-99E9-8771DD399B28Q38087987-1C224809-0EE1-4E72-A389-3FB948EC43CFQ38505122-F8E761BF-08E4-47BA-B99D-9164EFCD48CBQ38973135-035B6BC9-CBF9-44A4-B453-C8DE5067AE71Q39107176-3B300B53-8A29-4F1F-B770-001B77850736Q39409371-FF647819-7E6C-42FB-9217-C7476C6CB255Q39446810-E9E0CA3A-B674-4DBB-A2CB-269372EAC5B9Q41098235-1B614238-9ECF-4AF2-9F87-6E9504FDC1F8Q41551945-5AC22C04-1A86-4870-AFAC-6AB5B091D7C7Q41648580-C1AFEE4F-FD8D-47F4-ACE8-7D8C4C679955Q42176546-3BEA4545-E73B-40B6-811D-FBF0DD3191A7Q45323804-D0209EF5-6477-4779-9F48-2294672CD62CQ45872420-92BFF905-91C8-489B-8B1B-1B5D62433E10Q46410016-6DE1A500-49D4-4994-8681-ADE12433FDA2Q47551574-808F9B26-F08F-422B-84D4-77E2A2C015F2Q47554736-7B0EF34C-1401-45E3-B845-B7580B7392D2Q47618656-A2D20886-47CF-4806-A5E3-B88AB2985183Q50046042-B7BC00BF-260E-4631-80A5-0B253BAB8199Q50322555-80BDAA98-7B19-40B6-8409-F523B38073A2Q54241222-6D6915EB-1EC3-42F9-8B4E-17BDF380CC0EQ55508466-38799691-1E36-4101-9516-169EF0C4CCC6
P2860
Production, purification and characterization of adeno-associated vectors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Production, purification and characterization of adeno-associated vectors.
@en
Production, purification and characterization of adeno-associated vectors.
@nl
type
label
Production, purification and characterization of adeno-associated vectors.
@en
Production, purification and characterization of adeno-associated vectors.
@nl
prefLabel
Production, purification and characterization of adeno-associated vectors.
@en
Production, purification and characterization of adeno-associated vectors.
@nl
P1433
P1476
Production, purification and characterization of adeno-associated vectors
@en
P2093
Federico Mingozzi
P304
P356
10.2174/156652310793797685
P407
P577
2010-12-01T00:00:00Z